'Save younger patients': HC to Centre on Black Fungus drug

Updated : Jun 02, 2021 12:03
|
Editorji News Desk

The Delhi High Court on Tuesday asked the Centre to frame the policy on the distribution of the Liposomal Amphotericin B, a drug used in the treatment of black fungus. It added that younger people and those with better chances of survival should be prioritised, instead of older ones who have lived a full life.

The court asked the Centre to frame policy and file a status report on this regard and listed the matter for Friday. The court asked the Centre to take a policy decision on the distribution of the drug with inputs from medical professionals.

The court also suggested patients should be prioritised -- who have a better chance to survive so at least some lives can be saved.

The Court said that difficult choices have to be made and should be made at this stage. "If we have to choose, the young will have to be chosen. They are the future. 80-year olds are not going to carry this country forward. They have lived their lives," the court said.

Also Read | Is Yellow Fungus more dangerous: causes, symptoms and treatment

Black FungusDelhi High CourtCovid 19

Recommended For You

editorji | India

Editorji Launches Hook Global, Its International Digital News Brand

editorji | India

'Operation Tiger is complete,' roars Shinde as 6 Uddhav MPs join his Sena; calls them Dhurandhar

editorji | India

Kashmiri Pandits should move on, stop being prisoners of past: Mehbooba

editorji | India

At least 15 dead as fire rips through Lucknow building, students among victims

editorji | India

SC seeks responses of Centre, States on plea for use of Aadhaar as identity proof only